This inventor holds 4 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1985-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1987
Title: Inventor Profile: Kanji Tokuyama
Introduction
Kanji Tokuyama is a prominent inventor based in Osaka, Japan. He has dedicated his career to developing innovative processes and products, particularly in the field of pharmaceuticals. With a remarkable portfolio of four patents, Tokuyama continues to make significant contributions to the industry.
Latest Patents
Among Kanji Tokuyama’s latest patents are notable advancements in the purification of cephalosporins. His patented process involves contacting an aqueous solution of oxacephalosporin carboxylic acid with a macroporous polymeric adsorbent. This method effectively separates and purifies the compound from non-adsorbable contaminants, enhancing the efficiency of pharmaceutical production.
Another significant invention by Tokuyama is the production of hydroxymethylbutenoic acids via oxidation. This industrial chemical can be synthesized by oxidizing a specific oxazolinoazetidinylhalomethylbutenoic acid derivative. The innovative approach outlined in his patent showcases the potential for developing useful intermediates in the chemical industry.
Career Highlights
Kanji Tokuyama is affiliated with Shionogi & Company Limited, a well-respected entity in pharmaceutical development. His work includes the application of advanced chemical processes aimed at improving drug efficacy and safety. Tokuyama’s expertise and innovative thinking have solidified his reputation in the field.
Collaborations
Throughout his career, Kanji Tokuyama has collaborated with talented professionals, including Mamoru Tanaka and Kenji Ikawa. These partnerships have fostered a creative environment for innovation and have contributed to the successful development of their patented technologies.
Conclusion
Kanji Tokuyama exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to improving drug development processes and underscore his role as a significant inventor. With ongoing collaborations and a focus on cutting-edge research, Tokuyama is poised to continue making a profound impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
